Results 251 to 260 of about 60,395 (277)
Some of the next articles are maybe not open access.
Integrative oncology: Addressing the global challenges of cancer prevention and treatment
Ca-A Cancer Journal for Clinicians, 2022Jun J Mao,, Msce +2 more
exaly
Mutagenic activity of topoisomerase I inhibitors
Clinical cancer research : an official journal of the American Association for Cancer ResearchTopoisomerase I-directed agents are now in Phase I and II clinical trials and show great promise as potentially important agents for cancer chemotherapy. Because of their mechanism of action they may also be potential mutagens; however, their mutagenicity and oncogenicity still remain to be elucidated.
, Hashimoto, , Chatterjee, , Berger
openaire +1 more source
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma
Ca-A Cancer Journal for Clinicians, 2020Aaron J Grossberg +2 more
exaly
DNA topoisomerase I inhibitors.
Cancer chemotherapy and biological response modifiers, 1998C H, Takimoto, L V, Kieffer, S G, Arbuck
openaire +1 more source
Oral complications of cancer and cancer therapy
Ca-A Cancer Journal for Clinicians, 2012Joel B Epstein +2 more
exaly
American Cancer Society Head and Neck Cancer Survivorship Care Guideline
Ca-A Cancer Journal for Clinicians, 2016Nader Sadeghi +2 more
exaly